Is TCBP or NOBL a better dividend investment in 2026?

TCBP currently yields 400.00% with a 5% 5-year dividend growth rate. NOBL yields 2.17% with 5% growth. The better choice depends on your goal: TCBP offers higher current income.

What is the dividend yield difference between TCBP and NOBL?

TCBP has a forward dividend yield of 400.00% ($2.00/share annually). NOBL yields 2.17% ($2.27/share annually). The yield gap is 397.83 percentage points.

Home › Compare › TCBP vs NOBL

TCBP vs NOBL: Dividend Comparison 2026

TCBP yields 400.00% · NOBL yields 2.17%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TCBP wins by $11437.80M in total portfolio value

INVESTMENT

TIME HORIZON10 years

TCBP

● Live price

400.00%

Share price

$0.50

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$11437.82M

Annual income

$7,667,192,697.76

Full TCBP calculator →

NOBL

● Live price

2.17%

Share price

$104.67

Annual div

$2.27

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.9K

Annual income

$249.78

Full NOBL calculator →

Portfolio growth — TCBP vs NOBL

📍 TCBP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TCBP	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TCBP + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TCBP pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TCBP

Annual income on $10K today (after 15% tax)

$34,000.00/yr

After 10yr DRIP, annual income (after tax)

$6,517,113,793.10/yr

NOBL

Annual income on $10K today (after 15% tax)

$184.52/yr

After 10yr DRIP, annual income (after tax)

$212.31/yr

At 15% tax rate, TCBP beats the other by $6,517,113,580.78/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TCBP + NOBL for your $10,000?

TCBP: 50%NOBL: 50%

100% NOBL50/50100% TCBP

Portfolio after 10yr

$5718.92M

Annual income

$3,833,596,473.77/yr

Blended yield

67.03%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on TCBP right now

TCBP

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-14.7

Piotroski

2/9

NOBL

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TCBP buys

NOBL buys

No recent congressional trades found for TCBP or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTCBPNOBL

Forward yield	400.00% ✓	2.17%
Annual dividend / share	$2.00	$2.27 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$11437.82M ✓	$22.9K
Annual income after 10y	$7,667,192,697.76 ✓	$249.78
Total dividends collected	$11090.87M ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: TCBP vs NOBL ($10,000, DRIP)

Year	TCBP Portfolio	TCBP Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$50,700	$40,000.00	$10,917	$217.08	+$39.8K → TCBP
2	$243,782	$189,532.71	$11,903	$221.48	+$231.9K → TCBP
3	$1,112,560	$851,713.55	$12,962	$225.68	+$1.10M → TCBP
4	$4,823,161	$3,632,721.39	$14,099	$229.68	+$4.81M → TCBP
5	$19,879,046	$14,718,264.42	$15,319	$233.49	+$19.86M → TCBP
6	$77,964,520	$56,693,940.88	$16,628	$237.10	+$77.95M → TCBP
7	$291,226,244	$207,804,207.46	$18,033	$240.53	+$291.21M → TCBP
8	$1,037,056,355	$725,444,273.70	$19,539	$243.78	+$1037.04M → TCBP
9	$3,523,955,262	$2,414,304,962.28	$21,154	$246.86	+$3523.93M → TCBP
10	$11,437,824,828	$7,667,192,697.76	$22,884	$249.78	+$11437.80M → TCBP

TCBP vs NOBL: Complete Analysis 2026

TCBP — Stock

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Full TCBP Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →

📬

Get this TCBP vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TCBP vs SCHD TCBP vs JEPI TCBP vs O TCBP vs KO TCBP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.